AR
MRTX

Advisory Research’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Advisory Research’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,274
Closed -$1.32M – 356
2019
Q4 		$1.32M Buy
10,274
+4,128
+67% +$532K 0.06% 150
2019
Q3 		$479K Sell
6,146
-7,724
-56% -$602K 0.02% 254
2019
Q2 		$1.43M Buy
+13,870
New +$1.43M 0.03% 216